EUCTR2005-000192-17-GB进行中（未招募）1 期
Gemcitabine and Oxaliplatin in the treatment of locally advanced or metastatic transitional cell carcinoma of the urinary tract in patients with impaired renal function and patients who have progressed on a cisplatin-based regimen - GO-80 protocol in TCC urinary tract
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Locally-invasive or metastatic transitional cell carcinoma of the urinary tract – from the renal pelvis to the bladder.
- •2. Males and females >16 years of age.
- •3. Life expectancy >12 weeks.
- •4. ECOG performance status 0–3 (see appendix).
- •5. Adequate bone marrow function (to be determined within 14 days of randomisation):
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Previous chemotherapy with gemcitabine or oxaliplatin
- •2. Untreated patients with a creatinine clearance > 60 ml/min
- •3. Concurrent participation in any other investigational drug study.
- •4. Unable to give written informed consent
研究者
相似试验
已完成
2 期
Phase II study of gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced biliary tract cancer (JASPAC02)gemcitabine refractory advanced biliary tract cancerJPRN-UMIN000003650Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)40
进行中（未招募）
1 期
Fase II trial with gemcitabine and oxaliplatin in patients with unknown primary tumours - UPT - unfitTo test the effect of Gemcitabine and axaliplatin in patients with unknown primary tumours and performance 2 or age 66 to 75EUCTR2005-001959-38-DKGedske Daugaard39
尚未招募
2 期
Triple drug therapy in advanced gall bladder cancerCTRI/2023/10/058358CI, AIIMS
已完成
2 期
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with refractory germ cell cancergerm cell cancerJPRN-UMIN000017471Department of Urology, Tohoku University Graduate School of Medicine10
招募中
不适用
A Randomized study comparing Gemcitabine and oxaliplatin vs gemcitabine and capecitabine in patients with unresectable Carcinoma gall bladder with obstructive jaundice after PTBD/stenting (PTBD or ERCP)CTRI/2015/09/006175AIIMS104